Your browser doesn't support javascript.
loading
Inhibition of MICA and MICB shedding enhances memory-like NK-cell-mediated cytotoxicity against multiple myeloma.
Tahri, Sabrin; Piccinelli, Sara; Su, Nang Kham; Lampe, Luisa; Dong, Han; Vergara Cadavid, Juliana; Boiarsky, Rebecca; Papazian, Natalie; Lightbody, Elizabeth D; Cao, Amanda; Alberge, Jean-Baptiste; Ferrari de Andrade, Lucas; Rahmat, Mahshid; Shen, Yujia; Blanco Fernández, Laura; Zabaleta, Aintzane; Günther, Andreas; Getz, Gad; Sonneveld, Pieter; Cupedo, Tom; Wucherpfennig, Kai W; Ghobrial, Irene M; Romee, Rizwan.
Afiliação
  • Tahri S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Piccinelli S; Department of Medical Oncology, Harvard Medical School, Boston, MA.
  • Su NK; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA.
  • Lampe L; Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA.
  • Dong H; Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Vergara Cadavid J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Boiarsky R; Department of Medical Oncology, Harvard Medical School, Boston, MA.
  • Papazian N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Lightbody ED; Department of Medical Oncology, Harvard Medical School, Boston, MA.
  • Cao A; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA.
  • Alberge JB; Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA.
  • Ferrari de Andrade L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Rahmat M; Department of Medical Oncology, Harvard Medical School, Boston, MA.
  • Shen Y; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA.
  • Blanco Fernández L; Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA.
  • Zabaleta A; Medical Department, Christian-Albrechts University, Kiel, Germany.
  • Günther A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Getz G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Sonneveld P; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA.
  • Cupedo T; Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA.
  • Wucherpfennig KW; Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Ghobrial IM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Romee R; Department of Medical Oncology, Harvard Medical School, Boston, MA.
Blood Adv ; 8(20): 5365-5370, 2024 Oct 22.
Article em En | MEDLINE | ID: mdl-39106432
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Antígenos de Histocompatibilidade Classe I / Mieloma Múltiplo Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Antígenos de Histocompatibilidade Classe I / Mieloma Múltiplo Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article